Status:
COMPLETED
Effects of a New Combination of Nutraceuticals (AkP06) Without Monacolin K on Plasma Lipids and Glucose
Lead Sponsor:
Federico II University
Conditions:
Cardiovascular Risk Factor
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The study is designed evaluate the effects of a new combination of nutraceuticals (AkP 06) without Monacolin K on lipid and glucose metabolism. The study will analyze the impact of 4 weeks treatment ...
Detailed Description
The experimental design involves the construction of a placebo-controlled, randomized, single-blind, parallel-groups. Patients with mild hypercholesterolemia, of both sexes and aged between 18 and 75...
Eligibility Criteria
Inclusion
- Total Cholesterol\<300 mg/dL
- Total Cholesterol\>200 mg/dL
- Cardiovascular Risk\<20%
Exclusion
- Pregnancy
- Documented intolerance to one or more components of AkP06
- Previous cardiovascular events
- Familiar severe dyslipidemia
- Familiar high cardiovascular risk Hepatic or muscular disorders Subjects receiving lipid-lowering drugs
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03340285
Start Date
December 1 2017
End Date
December 1 2018
Last Update
July 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Raffaele Izzo
Naples, Italy, 80131